Viatris, Inc. (VTRS)
Evaluation: Based on all recent filings, financial statements, and news.
See full evaluationAsk a question about Viatris, Inc. (VTRS)
Go deeper and ask any question about VTRS
Company Performance
Current Price
as of Sep 18, 2024$11.90
P/E Ratio
N/A
Market Cap
$14.2B
Description
Viatris, Inc. is a global healthcare company, which engages in the provision of access to medicines and sustainable operations. It also offers support services such as diagnostic clinics, educational seminars, and digital tools. The firm operates through the following segments: Developed Markets, Greater China, JANZ, and Emerging Markets. The Developed Markets segment consists of operations primarily in North America and Europe. The Greater China segment includes operations in mainland China, Taiwan and Hong Kong. The JANZ segment consists of operations in Japan, Australia and New Zealand. The Emerging Markets segment encompasses operations with developing markets and emerging economies including countries in Asia, the Middle East, South and Central America, Africa and Eastern Europe. The company was founded on February 14, 2019 and is headquartered in Canonsburg, PA.
Metrics
Overview
- HQCanonsburg, PA
- SectorHealth Technology
- IndustryPharmaceuticals: Major
- TickerVTRS
- Price$11.9+0.68%
Trading Information
- Market Cap$14.20B
- Float97.95%
- Average Daily Volume (1m)6,790,999
- Average Daily Volume (3m)8,316,299
- EPS-$0.54
Company
- Revenue$15.19B
- Rev Growth (1yr)-3.18%
- Net Income-$326.40M
- Gross Margin38.21%
- EBITDA Margin20.75%
- EBITDA$785.80M
- EV$29.03B
- EV/Revenue1.91
- P/EN/A
- P/S0.93